Porcine marginal mass islet autografts resist metabolic failure over time and are enhanced by early treatment with liraglutide.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Endocrinology

• Publication date

  2009-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/en.2008-1116PMID 19131571
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice.

  2008cited by this paper
• Liraglutide, a Once‐daily Human Glucagon‐like Peptide‐1 Analog, Minimizes Food Intake in Severely Obese Minipigs

  2007cited by this paper
• Caspase Inhibitor Therapy Enhances Marginal Mass Islet Graft Survival and Preserves Long-Term Function in Islet Transplantation

  2007cited by this paper
• Influence of diabetes on the loss of beta cell differentiation after islet transplantation in rats

  2007cited by this paper
• Human Islet Amyloid Polypeptide Oligomers Disrupt Cell Coupling, Induce Apoptosis, and Impair Insulin Secretion in Isolated Human Islets

  2007cited by this paper
• The role of total pancreatectomy and islet autotransplantation for chronic pancreatitis.

  2007cited by this paper
• Effect of Exenatide on &bgr; Cell Function After Islet Transplantation in Type 1 Diabetes

  2007cited by this paper
• Prolonged Survival of Allogeneic Islets in Cynomolgus Monkeys After Short‐Term Anti‐CD154‐Based Therapy: Nonimmunologic Graft Failure?

  2006cited by this paper
• Exendin-4 treatment improves metabolic control after rat islet transplantation to athymic mice with streptozotocin-induced diabetes

  2006cited by this paper
• International trial of the Edmonton protocol for islet transplantation.

  2006cited by this paper
• Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1)

  2006cited by this paper
• The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits beta-cell apoptosis in vitro.

  2005cited by this paper
• Is aggregated IAPP a cause of beta-cell failure in transplanted human pancreatic islets?

  2005cited by this paper
• Five-year follow-up after clinical islet transplantation.

  2005cited by this paper
• XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes.

  2005cited by this paper
• Variation in human islet viability based on different membrane integrity stains.

  2004cited by this paper
• Variation in Human Islet Viability Based on Different Membrane Integrity Stains

  2004cited by this paper
• Chemokines in islet allograft rejection

  2003cited by this paper
• NN2211: a long-acting glucagon-like peptide-1 derivative with anti-diabetic effects in glucose-intolerant pigs.

  2002cited by this paper
• Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia.

  2002cited by this paper
• Cultured pancreatic ductal cells undergo cell cycle re-distribution and beta-cell-like differentiation in response to glucagon-like peptide-1.

  2002cited by this paper
• Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.

  2001cited by this paper
• Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

  2000cited by this paper
• Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration.

  2000cited by this paper
• Isolation of Adult Porcine Islets of Langerhans

  2000cited by this paper
• Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass.

  1998cited by this paper
• Expression of islet amyloid polypeptide in fetal and adult porcine and human pancreatic islet cells.

  1996cited by this paper
• Expression of islet amyloid polypeptide in fetal and adult porcine and human pancreatic islet cells.

  1996cited by this paper
• Islet isolation assessment in man and large animals

  1990cited by this paper
• Large-Scale Purification of Human Islets Utilizing Discontinuous Albumin Gradient on IBM 2991 Cell Separator

  1989cited by this paper
• Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques.

  1988cited by this paper
• Glucagon-like peptide-1 (7-36 amide): a potent glucagonostatic and insulinotropic hormone.

  1988cited by this paper
• Natural history of intrahepatic canine islet cell autografts.

  1986cited by this paper
• Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas.

  1985cited by this paper

• Microneedle patch with pure drug tips for delivery of liraglutide: pharmacokinetics in rats and minipigs

  2024cites this paper
• Alpha-cell paracrine signaling in the regulation of beta-cell insulin secretion

  2022cites this paper
• Pancreatic Islet Cell Transplantation: Graft Stability and Metabolic Outcomes

  2020cites this paper
• Comparison of the Effects of Liraglutide on Islet Graft Survival Between Local and Systemic Delivery

  2020cites this paper
• Inventing Liraglutide, a Glucagon-Like Peptide-1 Analogue, for the Treatment of Diabetes and Obesity.

  2019cites this paper
• Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions.

  2018cites this paper
• Recent progress in porcine islet isolation, culture and engraftment strategies for xenotransplantation

  2018cites this paper
• Synergistic Effects of Ad-Libitum Low-Dose Fructose Drinking and Low-Dose Streptozotocin Treatment in Wistar Rats: A Mild Model of Type 2 Diabetes.

  2017cites this paper
• Animal Models of Type 1 and Type 2 Diabetes Mellitus

  2017cites this paper
• GLP-1 Receptor Agonists for the Treatment of Diabetes and Obesity

  2017cites this paper
• MRI tracking of autologous pancreatic progenitor-derived insulin-producing cells in monkeys

  2017cites this paper
• Sitagliptin Treatment After Total Pancreatectomy With Islet Autotransplantation: A Randomized, Placebo‐Controlled Study

  2017cites this paper
• In Vitro and In Vivo Investigation of the Angiogenic Effects of Liraglutide during Islet Transplantation

  2016cites this paper
• Incretin actions and consequences of incretin‐based therapies: lessons from complementary animal models

  2016cites this paper
• Improvement of pancreatic islets viability in the bioartificial pancreas

  2016cites this paper
• Clinical implementation of islet transplantation: A current assessment

  2015cites this paper
• Antiaging Glycopeptide Protects Human Islets Against Tacrolimus-Related Injury and Facilitates Engraftment in Mice

  2015cites this paper
• Effects of the glucagon-like peptide-1 receptor agonist liraglutide in juvenile transgenic pigs modeling a pre-diabetic condition

  2015cites this paper
• Function and expression of sulfonylurea, adrenergic, and glucagon‐like peptide 1 receptors in isolated porcine islets

  2014cites this paper
• Long‐term Outcomes after Islet Transplantation

  2014cites this paper
• Liraglutide ameliorates glycometabolism and insulin resistance through the upregulation of GLUT4 in diabetic KKAy mice.

  2013cites this paper
• Anti-Inflammatory Strategies to Enhance Islet Engraftment and Survival

  2013cites this paper
• Establishment of a Stringent Large Animal Model of Insulin-Dependent Diabetes for Islet Autotransplantation: Combination of Pancreatectomy and Streptozotocin

  2013cites this paper
• Glucagon-like peptide-1 preserves coronary microvascular endothelial function after cardiac arrest and resuscitation: potential antioxidant effects.

  2013cites this paper
• Has pancreatic damage from glucagon suppressing diabetes drugs been underplayed?

  2013cites this paper
• Use of Glucagon-Like Peptide-1 Agonists to Improve Islet Graft Performance

  2013cites this paper
• DIABETIC STUDIES The Review of Chapter V . 1 Islet Transplantation in Type 1 Diabetes : Ongoing Challenges , Refined Procedures , and Long-Term Outcome

  2013cites this paper
• Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome.

  2012cites this paper
• Accumulation of intrahepatic islet amyloid in a nonhuman primate transplant model.

  2012cites this paper
• The use of animal models in diabetes research

  2012cites this paper
• Caspase Inhibitor IDN6556 Facilitates Marginal Mass Islet Engraftment in a Porcine Islet Autotransplant Model

  2012cites this paper
• Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets

  2011cites this paper
• Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.

  2011cites this paper
• Pharmacological management of type 2 diabetes: the potential of incretin‐based therapies

  2011cites this paper
• Strategies toward single-donor islets of Langerhans transplantation

  2011cites this paper
• The role of islet amyloid and CHOP in islet graft dysfunction and failure

  2011influential citation
• Liraglutide: the therapeutic promise from animal models

  2010cites this paper
• TLR4 Mediates Early Graft Failure After Intraportal Islet Transplantation

  2010cites this paper
• Liraglutide in islet transplantation: from bench to bedside *

  2010cites this paper
• Liraglutide, a long‐acting human glucagon‐like peptide 1 analogue, improves human islet survival in culture

  2010cites this paper
• Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts

  2010cites this paper
• Background and Purpose Experimental Approach Conclusions and Implications

  year unknowncites this paper